It is good to see this information in a medical publication, which will raise awareness through Pediatricians, however as many others have said it is not new news and why it wasn't marked as Market Sensitive
Anything Remestemcel-L IMO will only support the 'interest' from Novartis in finalising the current deal ....
Have a great night MSB'ers
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-56
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.204M | 1.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 208861 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 55290 | 59 |
View Market Depth
| Last trade - 15.38pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |